Monday, February 02, 2026 | 06:40 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch
Sensex (    %)
                             
Nifty (    %)
                             
Nifty Midcap(    %)
                             
Nifty Smallcap(    %)
                             
Nifty Bank(    %)
                             
Nifty IT(    %)
                             
Home / Markets / Alembic Pharmaceuticals Ltd / Announcements / BSE

Alembic Pharmaceuticals Ltd

Alembic Pharmaceuticals Limited - Press Release

12:00 AM, 27th Jan 2026

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 27, 2026, titled Alembic Pharmaceuticals Limited receives USFDA Final Approval for Difluprednate Ophthalmic Emulsion, 0.05%..